Back

Multi-Platform Assessment of DNA Sequencing Performance using Human and Bacterial Reference Genomes in the ABRF Next-Generation Sequencing Study

Foox, J.; Tighe, S. W.; Nicolet, C. M.; Zook, J. M.; Byrska-Bishop, M.; Clarke, W. E.; Khayat, M. M.; Mahmoud, M.; Laaguiby, P. K.; Herbert, Z. T.; Warner, D.; Grills, G. S.; Levy, S.; Schroth, G. P.; Sedlazeck, F. J.; Narzisi, G.; Farmerie, W.; Baldwin, D. A.; Mason, C. E.; Mason, C.

2020-07-24 genomics
10.1101/2020.07.23.218602 bioRxiv
Show abstract

Massively parallel DNA sequencing is a critical tool for genomics research and clinical diagnostics. Here, we describe the Association of Biomolecular Resource Facilities (ABRF) Next-Generation Sequencing Phase II Study to measure quality and reproducibility of DNA sequencing. Replicates of human and bacterial reference DNA samples were generated across multiple sequencing platforms, including well-established technologies such as Illumina, ThermoFisher Ion Torrent, and Pacific Biosciences, as well as emerging technologies such as BGI, Genapsys, and Oxford Nanopore. A total of 202 datasets were generated to investigate the performance of a total of 16 sequencing platforms, including mappability of reads, coverage and error rates in difficult genomic regions, and detection of small-scale polymorphisms and large-scale structural variants. This study provides a comprehensive baseline resource for continual benchmarking as chemistries, methods, and platforms evolve for DNA sequencing.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.